Skip to content

Strengthening Families Living With HIV in Kenya

Strengthening Families Living With HIV in Kenya

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04588883
Enrollment
843
Registered
2020-10-19
Start date
2021-09-28
Completion date
2025-07-15
Last updated
2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Medication, ART, Depression, Anxiety, Hiv, PTSD, Trust

Brief summary

This study seeks to use a group-based microfinance/internal lending model to develop social capital among people with HIV in Kenya. This will create a context to deliver validated curriculum targeting intimate partner violence, positive parenting, agriculture, small business entrepreneurship, group-interpersonal therapy, and other determinants of well-being and ART adherence among people with HIV. The primary outcomes are viral suppression, ART adherence, and common mental disorders.

Detailed description

It is anticipated that involvement in an internal savings and lending program will create social capital among people with HIV and their guardians (in case of adolescents w HIV). This social capital accrual will be leveraged to support and disseminate social skills (i.e. positive parenting, conflict resolution), economic skills (i.e. entrepreneurship, farming), and health skills (i.e. ART adherence, retention in care to produce viral suppression). The overall outcome is improved social, health, and economic well-being.

Interventions

BEHAVIORALKuja Pamoja - HIV

Information has been provided in the treatment arm description.

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Criteria for inclusion of subjects include: * testing positive for HIV, confirmed by the Ministry of Health clinics * being at or older than 13 years of age * initiating care at a qualified Ministry of Health clinic in the catchment area, or intending to initiate care at such a clinic (see below for definition) * Any gender, age (13+ years), and comorbid disease states * Provide informed consent if adult, emancipated minor or mature minor * Provide assent if minor with guardian, who must provide informed consent Qualified clinical locations include * those with accessible and usable public land to convene weekly meetings, * no current program targeting families with HIV known to the Ministry of Health

Exclusion criteria

* Refusal to participate * Current participation in a similar program * Residing in a location with a similar program targeting patients with HIV * Not covered by inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Viral SuppressionChange from baseline to 3 yearsViral suppression is measured as an undetectable viral load using standard clinic procedures.
Anti-retroviral therapy AdherenceChange from baseline to 3 yearsAnti-retroviral therapy (ART) adherence will be measured by patient report using the adherence portions of the AIDS Clinical Trial Group (ACTG) Adherence tool and by refill history.
DepressionChange from baseline to 3 yearsDepression will be measured using the Beck's Depression Inventory. Higher scores mean more depressive symptoms present.
AnxietyChange from baseline to 3 yearsAnxiety will be measured using the Generalized Anxiety Disorder (GAD7) instrument. Higher score means more anxiety symptoms present.
Post-Traumatic Stress DisorderChange from baseline to 3 yearsPost-traumatic stress disorder (PTSD) will be measured using the PTSD symptom scale. Higher scores mean more PTSD symptoms present.

Secondary

MeasureTime frameDescription
Group entitativityChange from baseline to 3 yearsSocial cohesion (operationalized as group entitativity) will be measured using the Generalized Entitativity Measure (GEM). Higher score on this visual analogue scale means higher group entitativity.
Child-guardian conflictChange from baseline to 3 years.Child-guardian conflict will be measured using the Conflict Tactics Scale for children (CTS2-pc). Higher scale score means more conflict present; higher violence subscale scores mean more violent conflicts used.
Intimate partner violenceChange from baseline to 3 yearsFamily violence will be measured using the Conflict Tactics Scale (CTS-2). Higher scale scores mean more conflict present; higher violence/coercive subscale scores mean more violence and coercion present.
Food insecurityChange from baseline to 3 yearsFood security will be measured using the Household Food Insecurity Scale instrument. Higher scale scores mean higher food insecurity.
Social trustChange from baseline to 3 yearsSocial trust will be measured using a single validated item. This is a binary outcome with 1=presence of trust between respondent and other similar aged people with HIV.
Expectations of mutual supportChange from baseline to 3 years.Expectation of mutual support will be measured using the a single validated item. Higher score means higher expectation of mutual support between respondent and other similar-aged people with HIV.

Countries

Kenya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026